Transcriptomic Immune Profiling: A Precision Path Forward for Immunotherapy in Patients with Cervical Cancer?

Choose the health content that’s right for you, and get it delivered right in your inbox.

Sed sed mi quis lectus lobortis ultricies sed eget dolor. Sed in odio vitae orci condimentum fringilla non id ante. Nulla ac leo blandit lectus placerat pharetra. Integer fermentum faucibus dapibus. Nullam auctor in nunc id suscipit. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Donec vehicula lorem eu enim pulvinar condimentum. Sed rutrum augue lorem.

Pellentesque dictum risus a nisl rhoncus interdum. Pellentesque non sapien nec sapien semper vulputate sit amet sed leo. Aenean eu enim vitae ante eleifend feugiat ac in lacus. Proin nec augue odio. Sed ac feugiat tellus. Aliquam at pellentesque felis, ac sagittis massa. Donec eu pharetra nulla. In egestas rutrum sem, ac dignissim purus viverra eu. Proin nec mauris tortor. Sed viverra varius lacus, vel hendrerit tortor. Vivamus erat tortor, gravida ac ligula vitae, fringilla blandit turpis. Ut pulvinar ligula sit amet eleifend mollis. Duis pulvinar, diam ut fringilla finibus, ante est venenatis erat, et posuere nisl elit malesuada quam. Quisque elementum ligula id tellus sollicitudin scelerisque et et mauris. Curabitur et ipsum eget erat sagittis ultricies. Cras sit amet arcu in mi interdum facilisis quis nec sapien.

View the poster

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease

While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...

News

AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)

Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...

News

AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease

Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...

News

AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease

Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...

News

AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training

With an aging population and increases in the prevalence of neurological conditions like Alzheimer’s disease and dementia, physicians and patients alike continue to seek new tools and approaches to...